Hypoprothrombinemia from Coadministration of Sulofenur (LY 186641) and Warfarin: Report of Three Cases
Overview
Overview
Journal
Invest New Drugs
Publisher
Springer
Specialty
Oncology
Date
1991 Nov 1
PMID
1804813
Citations
1
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Clinically significant drug interactions with the oral anticoagulants.
Freedman M, Olatidoye A Drug Saf. 1994; 10(5):381-94.
PMID: 8037888 DOI: 10.2165/00002018-199410050-00003.
References
1.
Solomon H, Schrogie J, Williams D
. The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids. Biochem Pharmacol. 1968; 17(1):143-51.
DOI: 10.1016/0006-2952(68)90166-4.
View
2.
AGGELER P, OReilly R, Leong L, Kowitz P
. Potentiation of anticoagulant effect of warfarin by phenylbutazone. N Engl J Med. 1967; 276(9):496-501.
DOI: 10.1056/NEJM196703022760904.
View
3.
Solomon H, Schrogie J
. The effect of various drugs on the binding of warfarin-14C to human albumin. Biochem Pharmacol. 1967; 16(7):1219-26.
DOI: 10.1016/0006-2952(67)90153-0.
View
4.
Taylor C, Alberts D, Ketcham M, Satterlee W, Holdsworth M, Plezia P
. Clinical pharmacology of a novel diarylsulfonylurea anticancer agent. J Clin Oncol. 1989; 7(11):1733-40.
DOI: 10.1200/JCO.1989.7.11.1733.
View
5.
EISEN M
. COMBINED EFFECT OF SODIUM WARFARIN AND PHENYLBUTAZONE. JAMA. 1964; 189:64-5.
DOI: 10.1001/jama.1964.03070010070021.
View